Dr. Goodman applies a consistent, evidence-based approach that integrates quantitative and fundamental analysis to inform investment decisions. Quantitative analysis leverages statistical models to evaluate financial data, while fundamental analysis assesses company financials and business metrics to determine competitive advantage and growth potential. This dual approach ensures a well-rounded evaluation of diverse factors that can influence investment outcomes.

Dr. Goodman’s portfolio management is methodical, maintaining a structured framework guided by established "alpha factors," such as analyst consensus ratings, company growth rates, and risk-adjusted historical market returns. Regular reviews and testing support this approach, ensuring consistency and alignment with long-term objectives, leading to evidence-based, informed investment decisions.

With over 19 years of experience in statistical programming, Dr. Goodman is proficient in portfolio analysis software development. He has led quantitative research at prominent institutions, including Stanford and Harvard, applying econometric and time-series analysis to study organizational growth. Since 2021, Dr. Goodman has managed portfolios at VegTech, focusing on food systems innovation companies in public markets.

Below are links to resources highlighting long-term trends in food innovation, driven by increasing demand for health-conscious and environmentally sustainable products:

​​​​

​

• Bloomberg Plant-based Innovation Sector Outlook, $162B by 2031 : here.

• BCG Plant-based Innovation Sector Outlook, $290B by 2035: here.

• BCG Impact Analysis, 3x-40x More Impact in Lowering GhGE than Other Green Sectors: here.

• ESG Clarity Sustainable Food Innovation Investing Impact Summation: here.

• Ernst & Young 2023 report shows good growth for food system transformation in Europe here.

• Capital Group highlights trends in food innovation here.